LB
29
-4
AVY
50
3
DUK
55
-2
DIS
70
-2
CVX
29
-2
AFL
45
-3
CMA
67
2
APD
52
2
FSLR
58
-2
PSA
35
-2
MDT
53
-2
NEE
54
2
GD
64
-2
VZ
42
3
DRI
58
-5
NRG
52
2
AVGO
45
3
BF.B
33
-2
D
46
3
TGT
57
5
LB
29
-4
AVY
50
3
DUK
55
-2
DIS
70
-2
CVX
29
-2
AFL
45
-3
CMA
67
2
APD
52
2
FSLR
58
-2
PSA
35
-2
MDT
53
-2
NEE
54
2
GD
64
-2
VZ
42
3
DRI
58
-5
NRG
52
2
AVGO
45
3
BF.B
33
-2
D
46
3
TGT
57
5
Financhill
Back

Eupraxia Pharmaceuticals, Inc. 10K Form

Buy
51

EPRX
Eupraxia Pharmaceuticals, Inc.

Last Price:
$7.65
Seasonality Move:
6.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EPRX News And Ratings

See the #1 stock for the next 7 days that we like better than EPRX

EPRX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-4.6M
Price / Cash Flow: 0
Annual Sales: $1.15
Price / Book: 6.56

Profitability

EPS (TTM): -0.86870
Net Income (TTM): $-29.4M
Gross Margin: $-171.7K
Return on Equity: -83.44%
Return on Assets: -77.22%

Eupraxia Pharmaceuticals, Inc. Earnings Forecast

Key Eupraxia Pharmaceuticals, Inc. Financial Ratios

  • Per Share Earnings over the last 8 years have been positive in 4 years.

Eupraxia Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EPRX
Website: eupraxiapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 23.98
Quick Ratio: 23.34

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EPRX Technical Analysis vs Fundamental Analysis

Buy
51
Eupraxia Pharmaceuticals, Inc. (EPRX) is a Buy

Is Eupraxia Pharmaceuticals, Inc. a Buy or a Sell?